Recurrent urinary tract infections (UTIs) in women are increasingly understood not just as pathogen-driven events but as conditions influenced by the urogenital microbiome, hormonal status, and mucosal immunity. Updated care models emphasize diagnostic confirmation, delayed and judicious antibiotic use, and prevention strategies such as vaginal estrogen, methenamine salts, and microbiome-supportive interventions , moving away from overreliance on long-term antibiotic prophylaxis. With emerging therapies like UTI vaccines and bacteriophage-based treatments on the horizon, management is shifting toward a holistic, individualized, and microbiome-centered approach that balances effective infection control with antimicrobial stewardship.
To read more; Click here Should restoring and protecting the microbiome become the cornerstone of recurrent UTI management? ##Reference## Siddiqui, Nazema…
